The largest database of trusted experimental protocols
> Disorders > Disease or Syndrome > Chronic Headache

Chronic Headache

Chronic Headache is a persistent or recurrent headache condition that can significantly impact an individual's quality of life.
It encompasses a wide range of primary and secondary headache disorders, such as migraine, tension-type headache, and medication-overuse headache.
These conditions are characterized by throbbing, stabbing, or dull pain in the head, neck, or face, often accompanied by other symptoms like nausea, vomiting, and sensitivity to light or sound.
Effective management of Chronic Headache involves a multidisciplinary approach, including pharmacological and non-pharmacological treatments, as well as lifestyle modifications.
Reserach in this area aims to improve understanding of the underlying pathophysiology, identify novel therapeutic targets, and develop more effective interventions to alleviate the burden of this debilitating condition.
Experiance the power of PubCompare.ai today to optimize your Chronic Headache reserach and take your work to the next level.

Most cited protocols related to «Chronic Headache»

Two reviewers applied inclusion criteria for potentially eligible papers separately, with disagreements about study inclusion resolved by consensus. Randomized trials were eligible for analysis if they included at least one group receiving acupuncture needling and one group receiving either sham (placebo) acupuncture or no acupuncture control. Trials must have accrued patients with one of four indications - non-specific back or neck pain, shoulder pain, chronic headache or osteoarthritis - with the additional criterion that the current episode of pain must be of at least four weeks duration for musculoskeletal disorders. There was no restriction on the type of outcome measure, although we specified that the primary endpoint must be measured more than four weeks after the initial acupuncture treatment.
It has been demonstrated that unconcealed allocation is the most important source of bias in randomized trials7 (link) and, as such, we included only those trials where allocation concealment was determined unambiguously to be adequate (further detail in the review protocol6 (link)). Where necessary, we contacted authors for further information concerning the exact logistics of the randomization process. Trials were excluded if there was any ambiguity about allocation concealment.
Publication 2012
Chronic Headache Degenerative Arthritides Musculoskeletal Diseases Neck Pain Pain Patients Placebos Shoulder Pain Therapy, Acupuncture

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2015
Abdominal Pain Adolescent Chronic Headache Dermatomyositis, Childhood Type Diagnosis Eligibility Determination Ethics Committees, Research Infectious Disease Contact Tracing Inflammation Juvenile Arthritis Lupus Erythematosus, Systemic Management, Pain Pain Pain Disorder Parent Patients Rheumatologist
Test-retest reliability testing was started after completion of stage 6 in March 2015 and lasted till September 2015. Consecutive convenience sampling in the Pain Center of the rehabilitation clinic “RehaClinic” in Bad Zurzach, Switzerland was performed to obtain a new sample different from the sample for testing the pre-final version (n = 36). Of those, n = 33 were recruited at the Pain Center and n = 3 from general practice, all suffering from chronic episodic headache. Sample size was pretermined. To detect an intraclass correlation coefficient (ICC) = 0.80 with a power = 80% and type I error = 0.05 a sample size of n = 36 patients was necessary [28 (link)].
All patients were tested twice with a time interval of 48 to 60 h between completed questionnaires. We assumed that 48 h was enough time for patients not to recall the results of the first completed questionnaire. By that, the 2 time windows of 90 days recall were highly congruent. For reliability testing, the period of 2 days was considered to be equivalent to that of 2 weeks [29 (link)]. The first questionnaire was given to the in-house patients on Friday and patients were asked to fill out the questionnaire on Friday evening after the last medical treatment. The second questionnaire was filled out on Monday morning before the first treatment. The time period in between was considered as stable because no medical treatment was administered.
Full text: Click here
Publication 2018
Chronic Headache Mental Recall Patients
To validate the classification interview we did paired telephone interviews with participants recruited from primary care as part of a feasibility study for CHESS. The feasibility study received Ethics approval from West Midlands – Black Country Research Ethics Committee (15/WM/0165).
We identified participants from searches of general practice records from 14 practices in the West Midlands region of the UK that cover urban, small town and semi-rural areas with varying levels of deprivation and ethnic diversity. We searched for people who had consulted within the previous year with headache, or had been prescribed migraine specific medication. Due to the typically imprecise coding of chronic headache in primary care and the fluctuating nature of headache frequency the search included people with both episodic and chronic headaches. GPs screened lists of participants identified from the searches and excluded those with known serious underlying pathology or secondary causes of headache (other than medication overuse headache) or terminal illness because we did not want to cause unnecessary upset or distress inviting them to take part in a study of a self-management intervention for chronic headache. People interested in the study were contacted by a member of the study team to confirm that they had experienced headaches for at least half the days of the month and for at least three months. People who met these criteria and provided written consent were invited to take part in two telephone interviews, the first a telephone classification interview conducted by specially trained nurses and the second a validation interview conducted by doctors working for the National Migraine Centre. The nurse interviews were audio recorded for quality assurance purposes.
Full text: Click here
Publication 2019
Analgesic Overuse Headache Chronic Headache Ethics Committees, Research Headache Migraine Disorders Nurses Pharmaceutical Preparations Physicians Primary Health Care Self-Management
As part of the ‘Behavioural and Environmental Assessment’ phase, surveys were conducted in 60 villages between February 2011 and January 2012. Since the main study is a community-based randomized control trial, the goal of the sampling was to compare the prevalence of active cysticercosis and the knowledge, attitudes and practices (KAP) relating to cysticercosis and taeniasis among participants through time. Therefore, the responses from the 80 participants per village are meant to represent KAP among those participants and are not meant to be generalized. However, we believe that the data represent the KAP pertaining to cysticercosis among people living in the 60 sampled villages and can be used to develop educational material for these communities. Such educational materials can be adapted to other endemic communities in the country.
Briefly, in each study province, all departments where pigs were raised (30 of 31 departments) were selected, and two villages meeting the eligibility criteria were randomly selected from each department for a total of 60 participating villages. Eligible villages had a population of at least 1 000 people as according to the 2006 census, were on the map provided by the Burkina Faso Geographic Institute (2000), were at least 5 km away from another participating village, were not located on a national or provincial road, were not the capital of the region or of the province, and were not located within 20 km of Koudougou or Ouagadougou. In each of the participating villages, 80 concessions were selected (a grouping of several households, usually members of the same family), including at least ten concessions with sows and at least 30 with pigs aged less than 12 months. One household was selected at random from each concession. In each sampled household, one eligible member was randomly selected to participate in a 3-year follow-up study on epilepsy and chronic headaches. As part of the follow-up study, participants had to answer a baseline questionnaire that was included in the present study (see Additional file 2). The inclusion criteria for participants in the baseline study and subsequent follow-up study were: aged at least 5 years, and having lived in the village for at least 12 months and not planning to move in the next 3 years. Figure 1 shows the location of villages used in the pilot study [4 (link)–6 (link)], the GDs, and the surveys.

Villages used in the pilot study, GDs, and questionnaire survey during the planning of the health education intervention strategy to control taeniasis and cysticercosis in Burkina Faso, 2007–2012. One village (green star) was involved in both the pilot and the main study

The surveys were largely based on a cysticercosis questionnaire developed by the Cysticercosis Working Group in Eastern and Southern Africa (CWGESA). They measured sociodemographic factors, behaviors related to pork consumption, and knowledge on porcine cysticercosis, taeniasis, and of the life cycle of T. solium. In the first 40 selected concessions with sows or piglets, a blood sample was taken from one pig to measure the presence of active infection with cysticercosis. The owner of the sampled pig was asked to answer a questionnaire regarding pig management and knowledge on porcine cysticercosis. All data were recorded on personal digital assistants (HP iPAQ Rx5910 Travel Companion, USA). These electronic devices allowed better quality control during data collection and prevented potential errors during data entry.
Full text: Click here
Publication 2017
BLOOD Chronic Headache Companions Cysticercosis Eligibility Determination Epilepsy Family Member Households Infection Medical Devices Pigs Pork Taeniases Teaching

Most recents protocols related to «Chronic Headache»

53. Migraine
54. Other chronic headache (including cluster headache, tension headache)
55. Epilepsy
56. Multiple sclerosis
57. Spina bifida
58. Idiopathic intracranial hypertension
59. Peripheral neuropathy
60. Other neurological conditions/musculoskeletal disorders
Full text: Click here
Publication 2023
Chronic Headache Cluster Headache Musculoskeletal Diseases Nervous System Disorder Tension Headache
DS-RPM currently handles the conditions listed in Table 1. Its algorithms were assembled from numerous online sources such as diagnostic algorithms (including differential diagnosis) and therapeutic interventions. We prioritized review articles, expert-panel papers, meta-analyses, selected clinical trials, plus case reports for uncommon conditions or atypical presentations. Our bibliography currently has over 300 references, categorized by reference type and areas of focus: diagnosis, differential diagnosis investigations, treatment, and patient education. We prioritize non-paywalled online content (e.g., PubMed + PubMed Central, Medscape) that is readily workplace accessible.

Primary diagnoses currently handled in DS-RPM

Tension-type headache
Migraine and its various presentations (e.g., with/without aura)
Cerebrovascular accident (CVA) and its subcategories
Intracranial space-occupying lesions of various etiologies (neoplasia, vascular, acute/chronic pituitary disorders)
Trigeminal autonomic cephalalgias—cluster headache, paroxysmal hemicrania, hemicrania continua, short-lasting unilateral neuralgiform headache with autonomic symptoms/conjunctival tearing (SUNA/SUNCT)
Neuralgic disorders: trigeminal neuralgia, glossopharyngeal neuralgia, occipital neuralgia, post-herpetic neuralgia
Systemic causes of headache: e.g., temporal (giant-cell) arteritis, pheochromocytoma, lupus erythematosus
Disorders of the salivary glands—sialadenitis, sialadenosis, neoplasia, Sjogren–Mikulicz disease
Temporomandibular joint disorders
Disorders of the paranasal sinuses
Infective causes of CNS inflammation—meningitis, encephalitis, HIV, Lyme disease
Toothache and its differential/root causes: Caries, abscess, trigeminal neuralgia, etc
Optic neuritis and its root causes (e.g., multiple sclerosis, neuromyelitis optica)
Ophthalmic causes of headache/facial pain (e.g., uveitis, keratoconjunctivitis, refractive errors)
Cavernous sinus disorders—thrombosis, Tolosa–Hunt syndrome
Our starting point for headache/facial pain was ICHD-3 (International Classification of Headache Disorders, 3rd Edition) [40 ]. While useful, we discovered numerous issues limiting its utility which is presented in the discussion section. We used several well-known questionnaires to quantify risk scores, which were used as the basis for customized recommendations:

Opioid risk (with the creators’ permission): the 8-item Revised (2019) Opioid Risk Tool for Opioid Use Disorder (ORT-OUD) [41 (link)]. The ORT-OUD Risk Score is used to generate a risk-stratified treatment plan for opioid use where appropriate.

Depression: Chronic pain can cause depression. The 9-item Patient Health Questionnaire (PHQ) is activated if the patient responds to either of two questions in the history (“Little pleasure in doing things”; “Feeling down, depressed, or hopeless”) with “More than half the days” or worse [42 (link)].

Suicide risk: The National Institute of Mental Health’s 4-item ASQ (Ask Suicide Screening Questions) scale is activated after a non-negative response to the PHQ question “Thoughts that you would be better off dead, or of hurting yourself.” Chronic pain is an important risk factor for suicide [43 (link)]: chronic headache posed higher suicide risk than other chronic pain types in a 10-year veterans’ retrospective study [44 (link)].

Full text: Click here
Publication 2023
Abscess Acute Disease BAD protein, human Blood Vessel Cavernous Sinus Thrombosis Cerebrovascular Accident Chronic Headache Chronic Pain Cluster Headache Conjunctiva Dental Caries Diagnosis Differential Diagnosis Disease, Chronic Education of Patients Encephalitis Facial Pain Giant Cell Arteritis Glossopharyngeal Neuralgia Headache Headache Disorders Hemicrania Inflammation Joints Keratoconjunctivitis Lupus Vulgaris Meningitis Multiple Sclerosis Neoplasms Nervous System, Autonomic Neuralgia Neuritis Neuromyelitis Optica Ocular Headache Opioids Opioid Use Disorder Paroxysmal Hemicrania Patients Pheochromocytoma Plant Roots Pleasure Refractive Errors Salivary Glands Sialadenitis Sjogren's Syndrome Thinking Trigeminal Autonomic Cephalalgias Trigeminal Neuralgia Uveitis Veterans
We recruited 22 subjects with chronic headache and 15 healthy subjects between November 2021 and April 2022. All subjects were recruited from the Affiliated Hospital of Shandong University of Traditional Chinese Medicine and were right-handed. All our subjects were formally recruited through registration and screening, excluding outpatients and inpatients. According to the diagnostic criteria of the chronic tension-type headache in the International Classification of Headache Disorders, 3rd edition (ICHD-3: Code 1.1, 2013) [18 (link)], patients with chronic tension-type headache were diagnosed by neurologists Professor Wu and Professor Li.
Publication 2023
Chronic Headache Headache Disorders Healthy Volunteers Inpatient Neurologists Outpatients Patients Tension Headache
For inclusion in this study, all patients had to meet the ICHD-3 diagnostic criteria of chronic tension-type headache [18 (link)]: mild or moderate nonpulsatile pain on both sides of the head, without photophobia, fear of sound, nausea, or vomiting. All cases evolved from episodic tension-type headache, but headache must last for at least 15 days per month for more than 3 months before it can be considered chronic headache. In addition, the severity of headache should not be affected by daily physical activity, and there should be no signs of secondary headache or medication-overuse headache.
Patients with chronic tension-type headache who were included in the examination could receive preventive or therapeutic treatment with pain-killing drugs with the doctors’ consent or when they have a headache.
Subjects in the healthy control group were required to be in a healthy state and have no headache within the last year, no medication in 1 month, and no family history of headache. The subjects did not consume alcohol, caffeine, or other substances for at least 3 days before MRI.
Publication 2023
Analgesic Overuse Headache Caffeine Chronic Headache Diagnosis Ethanol Fear Headache Healthy Volunteers Management, Pain Nausea Patients Pharmaceutical Preparations Photophobia Physical Examination Physicians Sound Tension Headache Therapeutics
Participants were dichotomized into those with chronic headaches (CH) and those with no such history (NH). Patients with physician-diagnosed and managed post-traumatic headaches and migraines were all included in the “chronic headaches” cohort. Though the mechanisms underlying the development of these two diseases are different, definitive clinical diagnosis one way or another can be difficult [26 (link), 27 (link)], especially among pediatric athletes involved in high contact sports. This difficulty can be attributed to the significant phenotypic overlap between the two conditions, including throbbing headache, pain on the side of the head, nausea, vomiting, and headache exacerbated by activity [28 (link)]. Additionally, pediatric patients report their symptoms and history of present illness less reliably, further increasing the difficulty of definitive diagnosis. Patients with chronic headaches of unspecified classification were also included in the analysis. In the clinical setting these cases should be followed longitudinally to determine and confirm an exact diagnosis. Given our study design, we lacked this privilege. However, excluding these cases would provide only a partial account of the chronic headache burden among the pediatric athlete sub-population [4 (link)]. Appropriate sample sizes for each cohort were derived using the equation below. n=[zα2PQ+zβp1q1+p2q2]2(p1-p2)2,whereP=x1+x2n1+n2andQ=1-P
According to the power analysis, we needed at least 524 patients in each group to detect a mean concussion incidence difference of 10% between the CH and NH cohorts, at 80% power and with a Type I error set at 0.05.
Chi-squared tests were used to compare categorical variables and concussion incidence. Continuous variables were presented as the mean ± standard deviation if they were normally distributed according to the Kolmogorov-Smirnov test. Means of normally distributed continuous variables were compared using a t-test. If not normally distributed, continuous variables were presented as the median and interquartile range. Medians were compared using the Kruskal-Wallis test. Significant univariate variables were included in a multivariate logistical regression to assess for risk factors of chronic headaches. Pertinent risk factors, specifically a history of concussions, were further analyzed as a function of chronic headache and symptom burden, as reported on the PCSS survey administered at the beginning of the season. Headache burden was rated on an overall scale ranging from 0 to 54 that assessed the intensity of headache, vomiting, nausea, balance, dizziness, sensitivity to light, sensitivity to noise, numbness, and visual changes on independent scales of 0 to 6. Symptom burden included all 22 measures on the baseline PCSS survey. For the analysis, past concussions were stratified by their number and characteristics, including confusion, anterograde amnesia, retrograde amnesia, and loss of consciousness.
Next, a multivariate model accounting for variables shown to modulate chronic headaches was used to compare the incidence of future concussion among those reporting a history chronic headache and those reporting no such history. Future concussion incidence was also analyzed as a function of initial headache burden. Separate multivariable logistic regressions were then conducted to assess for the role of chronic headaches on concussion severity and recovery as measured by deviations from baseline to PI and then to FU in the five composite scores. In the multivariate model assessing concussion recovery loss to FU, latency to FU, and deviations from baseline to PI in the five composite scores were included as confounding variables. Latency to FU was defined as the time elapsed between the PI and FU tests. A final set of multivariable linear regressions were used to assess the role of baseline demographic variables and headache burden on concussion severity and recovery.
A p-value < 0.05 was considered significant for all tests. RStudio 3.6 (R Foundation for Statistical Computing) was used for data analysis and Adobe Illustrator 27.0 (Adobe Incorporated) was used for figure creation.
Full text: Click here
Publication 2023
Amnesia, Anterograde Athletes Brain Concussion Chronic Headache Concussion, Severe Developmental Disabilities Diagnosis Differential Diagnosis Headache Hyperacusis Migraine Disorders Nausea Patients Phenotype Photophobia Post-Traumatic Headache Retrograde Amnesia Throbbing Headache

Top products related to «Chronic Headache»

Sourced in United States, Canada
EndNote is a reference management software that allows users to collect, organize, and format bibliographic citations and references. It provides a platform to manage research sources, create formatted bibliographies, and integrate citations into manuscripts and documents.
Sourced in United States, United Kingdom, Japan, Austria, Germany, Denmark, Czechia, Belgium, Sweden, New Zealand, Spain
SPSS version 25 is a statistical software package developed by IBM. It is designed to analyze and manage data, providing users with a wide range of statistical analysis tools and techniques. The software is widely used in various fields, including academia, research, and business, for data processing, analysis, and reporting purposes.
Sourced in United States, United Kingdom, Belgium, Japan, Austria, Germany, Denmark
SPSS Statistics for Windows is an analytical software package designed for data management, analysis, and reporting. It provides a comprehensive suite of tools for statistical analysis, including regression, correlation, and hypothesis testing. The software is intended to assist users in gaining insights from their data through advanced analytical techniques.
Sourced in United States, Japan, United Kingdom, Austria, Canada, Germany, Poland, Belgium, Lao People's Democratic Republic, China, Switzerland, Sweden, Finland, Spain, France
GraphPad Prism 7 is a data analysis and graphing software. It provides tools for data organization, curve fitting, statistical analysis, and visualization. Prism 7 supports a variety of data types and file formats, enabling users to create high-quality scientific graphs and publications.
Sourced in United States
SPSS Statistics for Windows v.23 is a comprehensive and interactive software suite designed for statistical analysis. It provides a wide range of analytical tools and techniques to help researchers, analysts, and organizations effectively manage, analyze, and present data. The software offers a user-friendly interface and a robust set of statistical methods for data exploration, modeling, and reporting.

More about "Chronic Headache"

Persistent Headache, Recurrent Headache, Migraine, Tension-Type Headache, Medication-Overuse Headache, Throbbing Pain, Stabbing Pain, Dull Pain, Nausea, Vomiting, Light/Sound Sensitivity, Multimodal Treatment, Pharmacological Therapy, Non-Pharmacological Therapy, Lifestyle Modifications, Pathophysiology, Therapeutic Targets, Headache Burden, SPSS, GraphPad Prism, EndNote.
Chronic headaches are a debilitating condition characterized by recurring, long-lasting head, neck, or facial pain.
These headaches can significantly impact an individual's quality of life and encompass a wide range of primary and secondary headache disorders, such as migraine, tension-type headache, and medication-overuse headahe.
Individuals with chronic headaches often experience throbbing, stabbing, or dull pain, accompanied by other symptoms like nausea, vomiting, and sensitivity to light or sound.
Effective management of chronic headaches requires a multidisciplinary approach, including pharmacological and non-pharmacological treatments, as well as lifestyle modifications.
Reserach in this area aims to improve understanding of the underlying pathophysiology, identify novel therapeutic targets, and develop more effective interventions to alleviate the burden of this debilitating condition.
Tools like SPSS, GraphPad Prism, and EndNote can be leveraged to optimize data analysis and streamline the research process.
Experiance the power of PubCompare.ai today to take your chronic headache reserach to the next level.